Wave Life Sciences (WVE) Revenue (2015 - 2026)
Wave Life Sciences' (WVE) quarterly Revenue came in at $2.3 million in Q2 2026, down 73.88% YoY from $8.7 million in Q2 2025, and down 94.06% on a QoQ basis from $38.2 million in Q1 2026.
Wave Life Sciences (WVE) Revenue (2015 - 2026) Analysis & Trends
Wave Life Sciences (WVE) has 12 years of Revenue data on file, last reported at $2.3 million in Q2 2026.
- Quarterly Revenue fell 73.88% year-over-year to $2.3 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $58.4 million (up 16.54% YoY) and the FY2025 annual result came in at $42.7 million, down 60.55% from the prior year.
- Revenue slipped to $2.3 million in Q2 2026, from $38.2 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $49.2 million in Q3 2023 to a low of $285000.0 in Q3 2022.
- A 5-year average of $14.8 million and a median of $10.9 million in 2024 frame the typical range for Revenue.
- Annual changes were most pronounced in 2022 — Revenue slumped 99.22% — and 2023, when it surged 17168.07%.
- Tracing WVE's Revenue over 5 years: stood at $1.2 million in 2022, then surged by 2245.12% to $29.1 million in 2023, then plunged by 32.23% to $19.7 million in 2024, then tumbled by 55.82% to $8.7 million in 2025, then tumbled by 73.88% to $2.3 million in 2026.
- The last three Revenue figures came in at $2.3 million (Q2 2026), $38.2 million (Q1 2026), and $8.7 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Wave Life Sciences | 1.05 Bn | 677.62 Mn | - | 2.27 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.27 Mn |
| Mar 31, 2026 | 38.25 Mn |
| Jun 30, 2025 | 8.70 Mn |
| Mar 31, 2025 | 9.18 Mn |
| Jun 30, 2024 | 19.69 Mn |
| Mar 31, 2024 | 12.54 Mn |
| Dec 31, 2023 | 29.06 Mn |
| Sep 30, 2023 | 49.21 Mn |
| Jun 30, 2023 | 22.11 Mn |
| Mar 31, 2023 | 12.93 Mn |
| Dec 31, 2022 | 1.24 Mn |
| Sep 30, 2022 | 285,000.00 |
| Jun 30, 2022 | 375,000.00 |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 1.77 Mn |
| Sep 30, 2021 | 36.42 Mn |
| Jun 30, 2021 | 2.78 Mn |
| Dec 31, 2020 | 9.44 Mn |
| Sep 30, 2020 | 3.45 Mn |
| Jun 30, 2020 | 3.03 Mn |